Minerva Neurosciences | Işletme Karı

Operating Profit Değişiklik Tarih
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Adma Biologics USD -11941000 20.63M 2023-12
ALKERMES USD 43.85M 195.34M 2023-09
AstraZeneca USD 1.95B 502M 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Cipla INR 14.44B 1.89B 2023-09
Clal Biotechnology ILS -1738000 7.46M 2022-12
Compugen USD -10628000 414K 2023-09
CSL USD 934.7M 1.2B 2023-06
Dynavax Technologies USD -8491000 13.61M 2023-12
Eli Lilly USD 2.39B 1.94B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Grifols EUR 250.59M 7.19M 2023-09
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Merck USD -1933000000 7.68B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Takeda JPY -49342000000 217.91B 2023-09



Minerva Neurosciences Işletme Karı - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Apr 2024.